Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabhakar Pitta Venkata

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Molecular Biosciences|April 7, 2023
Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasisSubramanyam Dasari, Prabhakar Pitta Venkata, Uday P Pratap, et al.
Stem Cells (Dayton, Ohio)|January 20, 2021
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cellsGangadhara R Sareddy, Uday P Pratap, Prabhakar Pitta Venkata, et al.
Scientific Reports|April 18, 2019
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathwaysMei Zhou, Gangadhara R Sareddy, Mengxing Li, et al.
Journal of Applied Toxicology : JAT|January 9, 2019
Acute and subacute oral toxicity of copper oxide nanoparticles in female albino Wistar ratsLakshmi Sai Pratyusha Bugata, Prabhakar Pitta Venkata, Ananth Reddy Gundu, et al.
International Journal of Molecular Sciences|July 9, 2022
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta AgonistYi He, Salvador Alejo, Prabhakar Pitta Venkata, et al.
Neuro-Oncology Advances|April 21, 2020
PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signalingGangadhara R Sareddy, Uday P Pratap, Suryavathi Viswanadhapalli, et al.
Neuro-Oncology Advances|September 6, 2021
Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastomaUday P Pratap, Gangadhara R Sareddy, Zexuan Liu, et al.
Breast Cancer Research and Treatment|October 15, 2020
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancerMei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, et al.
Cancer Letters|October 21, 2021
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancerPrabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, et al.
Molecular Cancer Therapeutics|June 26, 2025
Targeting DDR2 for Treating Pancreatic CancerChris Tp Do, Prabhakar Pitta Venkata, Jack Y Prochnau, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Molecular Biosciences|April 7, 2023
Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasisSubramanyam Dasari, Prabhakar Pitta Venkata, Uday P Pratap, et al.
Stem Cells (Dayton, Ohio)|January 20, 2021
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cellsGangadhara R Sareddy, Uday P Pratap, Prabhakar Pitta Venkata, et al.
Scientific Reports|April 18, 2019
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathwaysMei Zhou, Gangadhara R Sareddy, Mengxing Li, et al.
Journal of Applied Toxicology : JAT|January 9, 2019
Acute and subacute oral toxicity of copper oxide nanoparticles in female albino Wistar ratsLakshmi Sai Pratyusha Bugata, Prabhakar Pitta Venkata, Ananth Reddy Gundu, et al.
International Journal of Molecular Sciences|July 9, 2022
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta AgonistYi He, Salvador Alejo, Prabhakar Pitta Venkata, et al.
Neuro-Oncology Advances|April 21, 2020
PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signalingGangadhara R Sareddy, Uday P Pratap, Suryavathi Viswanadhapalli, et al.
Neuro-Oncology Advances|September 6, 2021
Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastomaUday P Pratap, Gangadhara R Sareddy, Zexuan Liu, et al.
Breast Cancer Research and Treatment|October 15, 2020
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancerMei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, et al.
Cancer Letters|October 21, 2021
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancerPrabhakar Pitta Venkata, Yihong Chen, Salvador Alejo, et al.
Molecular Cancer Therapeutics|June 26, 2025
Targeting DDR2 for Treating Pancreatic CancerChris Tp Do, Prabhakar Pitta Venkata, Jack Y Prochnau, et al.
Pageof 2